| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $965.7M | $1.07B | $1.05B |
| YoY Revenue Growth % | -9.9% | +1.9% | — |
| Gross Profit | $684.1M | $1.07B | — |
| Gross Margin % | 70.8% | 98.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$805.8M | -$700.5M | $53.4M |
| Operating Margin % | -80.0% | -65.4% | 5.1% |
| Net Income (GAAP) | -$693.1M | -$557.0M | -$4.2M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $250.4M | $123.4M | $182.1M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | $250.4M | $123.4M | $182.1M |
| FCF Margin % | 25.9% | 11.5% | 17.3% |
| Return on Invested Capital (ROIC %) | -45.0% | -44.9% | — |
| Cash & Short-Term Equivalents | $175.8M | $204.3M | — |
| Total Debt (Short + Long Term) | $582.7M | $611.3M | — |
| Total Stockholders' Equity | $570.0M | $824.5M | — |